{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:22:59Z","timestamp":1773285779425,"version":"3.50.1"},"reference-count":174,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/mjt.0b013e3181727d06","type":"journal-article","created":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T08:33:32Z","timestamp":1263285212000},"page":"e24-e40","source":"Crossref","is-referenced-by-count":8,"title":["Practical Implications of ACC\/AHA 2007 Guidelines for the Management of Unstable Angina\/Non-ST Elevation Myocardial Infarction"],"prefix":"10.1097","volume":"17","author":[{"given":"Pawan D","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit R","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5694\/j.1326-5377.2003.tb05474.x","article-title":"Aspirin for cardiovascular disease prevention.","volume":"179","author":"Hung","year":"2003","journal-title":"Med J Aust"},{"key":"R2-19-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2004.03.005","article-title":"Symptoms in acute coronary syndromes: does sex make a difference?","volume":"148","author":"Patel","year":"2004","journal-title":"Am Heart J"},{"key":"R3-19-20210202","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000097116.29625.7C","article-title":"Womens early warning symptoms of acute myocardial infarction.","volume":"108","author":"McSweeney","year":"2003","journal-title":"Circulation"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1553-2712.2000.tb02063.x","article-title":"Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial. REACT Study Group.","volume":"7","author":"Hedges","year":"2000","journal-title":"Acad Emerg Med"},{"key":"R5-19-20210202","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1161\/01.CIR.0000041246.20352.03","article-title":"Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2.","volume":"106","author":"Canto","year":"2002","journal-title":"Circulation"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00019501-200007000-00004","article-title":"Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT Trial. Rapid Early Action for Coronary Treatment.","volume":"11","author":"Goldberg","year":"2000","journal-title":"Coron Artery Dis"},{"key":"R7-19-20210202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-8703(03)00510-6","article-title":"Patients with chest pain calling 9-1-1 or self-transporting to reach definitive care: which mode is quicker?","volume":"147","author":"Hutchings","year":"2004","journal-title":"Am Heart J"},{"key":"R8-19-20210202","first-page":"I172","article-title":"Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 7: the era of reperfusion: section 1: acute coronary syndromes (acute myocardial infarction).","volume":"102","year":"2000","journal-title":"Circulation"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/01.CIR.102.2.173","article-title":"Demographic, belief, and situational factors influencing the decision to utilize emergency medical services among chest pain patients. Rapid Early Action for Coronary Treatment (REACT) study.","volume":"102","author":"Brown","year":"2000","journal-title":"Circulation"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/heart.84.2.137","article-title":"Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care.","volume":"84","author":"Leslie","year":"2000","journal-title":"Heart"},{"key":"R11-19-20210202","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0002-9149(72)90037-9","article-title":"Components of delay in the pre-hospital phase of acute myocardial infarction.","volume":"30","author":"Simon","year":"1972","journal-title":"Am J Cardiol"},{"key":"R12-19-20210202","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making.","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"R13-19-20210202","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"R14-19-20210202","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events.","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"key":"R15-19-20210202","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.CIR.101.22.2557","article-title":"Predictors of outcome in patients with acute coronary syndromes without persistent ST segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.","volume":"101","author":"Boersma","year":"2000","journal-title":"Circulation"},{"key":"R16-19-20210202","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jacc.2005.06.051","article-title":"The year in non-ST-segment elevation acute coronary syndromes.","volume":"46","author":"Giugliano","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R17-19-20210202","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.CIR.64.2.360","article-title":"Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS).","volume":"64","author":"Chaitman","year":"1981","journal-title":"Circulation"},{"key":"R18-19-20210202","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0002-9343(83)90406-0","article-title":"Estimating the likelihood of significant coronary artery disease.","volume":"75","author":"Pryor","year":"1983","journal-title":"Am J Med"},{"key":"R19-19-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-118-2-199301150-00001","article-title":"Value of the history and physical in identifying patients at increased risk for coronary artery disease.","volume":"118","author":"Pryor","year":"1993","journal-title":"Ann Intern Med"},{"key":"R20-19-20210202","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0002-9343(97)00086-7","article-title":"Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease.","volume":"102","author":"Morise","year":"1997","journal-title":"Am J Med"},{"key":"R21-19-20210202","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4065\/77.6.515","article-title":"Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease.","volume":"77","author":"Ho","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"R22-19-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/hj.1999.v137.95352","article-title":"Should we emergently revascularize occluded coronaries for cardiogenic shock: an international randomized trial of emergency PTCA\/CABG-trial design. The SHOCK Trial Study Group.","volume":"137","author":"Hochman","year":"1999","journal-title":"Am Heart J"},{"key":"R23-19-20210202","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.100.20.2067","article-title":"Cardiogenic shock in patients with acute ischemic syndromes with and without ST segment elevation.","volume":"100","author":"Holmes","year":"1999","journal-title":"Circulation"},{"key":"R24-19-20210202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.281.8.707","article-title":"Prognostic value of the admission electrocardiogram in acute coronary syndromes.","volume":"281","author":"Savonitto","year":"1999","journal-title":"JAMA"},{"key":"R25-19-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0196-0644(97)70298-1","article-title":"An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group [published correction appears in Ann Emerg Med. 1997;29:310].","volume":"29","author":"Selker","year":"1997","journal-title":"Ann Emerg Med"},{"key":"R26-19-20210202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0735-1097(98)00553-1","article-title":"Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?","volume":"33","author":"Zaacks","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R27-19-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0735-1097(97)00160-5","article-title":"The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia.","volume":"30","author":"Cannon","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R28-19-20210202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0002-9149(99)00319-7","article-title":"Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression.","volume":"84","author":"Hyde","year":"1999","journal-title":"Am J Cardiol"},{"key":"R29-19-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF02599421","article-title":"Impact of the availability of a prior electrocardiogram on the triage of the patient with acute chest pain.","volume":"5","author":"Lee","year":"1990","journal-title":"J Gen Intern Med"},{"key":"R30-19-20210202","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198505023121801","article-title":"Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction.","volume":"312","author":"Brush","year":"1985","journal-title":"N Engl J Med"},{"key":"R31-19-20210202","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00007611-199107000-00006","article-title":"Diagnostic and prognostic importance of comparing the initial to the previous electrocardiogram in patients admitted for suspected acute myocardial infarction.","volume":"84","author":"Fesmire","year":"1991","journal-title":"South Med J"},{"key":"R32-19-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0196-0644(98)70274-4","article-title":"Usefulness of automated serial 12-lead ECG monitoring during the initial emergency department evaluation of patients with chest pain.","volume":"31","author":"Fesmire","year":"1998","journal-title":"Ann Emerg Med"},{"key":"R33-19-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0735-1097(98)00175-2","article-title":"Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) project.","volume":"32","author":"Kudenchuk","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R34-19-20210202","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/hrt.75.3.222","article-title":"Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram.","volume":"75","author":"Patel","year":"1996","journal-title":"Heart"},{"key":"R35-19-20210202","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/euhj.1997.0586","article-title":"Long-term prognosis in unstable angina: the importance of early risk stratification using continuous ST segment monitoring.","volume":"19","author":"Patel","year":"1998","journal-title":"Eur Heart J"},{"key":"R36-19-20210202","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-8703(89)90742-4","article-title":"Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery.","volume":"117","author":"de Zwaan","year":"1989","journal-title":"Am Heart J"},{"key":"R37-19-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9149(83)90061-9","article-title":"Anatomic and prognostic significance of new T-wave inversion in unstable angina.","volume":"52","author":"Haines","year":"1983","journal-title":"Am J Cardiol"},{"key":"R38-19-20210202","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.82.3.913","article-title":"Reversal of segmental hypokinesis by coronary angioplasty in patients with unstable angina, persistent T wave inversion, and left anterior descending coronary artery stenosis. Additional evidence for myocardial stunning in humans.","volume":"82","author":"Renkin","year":"1990","journal-title":"Circulation"},{"key":"R39-19-20210202","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0002-9149(89)90857-6","article-title":"Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study).","volume":"64","author":"Rouan","year":"1989","journal-title":"Am J Cardiol"},{"key":"R40-19-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02600409","article-title":"Detecting acute cardiac ischemia in the emergency department: a review of the literature.","volume":"5","author":"McCarthy","year":"1990","journal-title":"J Gen Intern Med"},{"key":"R41-19-20210202","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/0002-9149(87)91020-4","article-title":"Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings.","volume":"60","author":"Slater","year":"1987","journal-title":"Am J Cardiol"},{"key":"R42-19-20210202","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0735-1097(99)00249-1","article-title":"Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: hidden ST-segment elevations revealing acute posterior infarction.","volume":"34","author":"Matetzky","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R43-19-20210202","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0002-9149(87)91091-5","article-title":"Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depression.","volume":"59","author":"Boden","year":"1987","journal-title":"Am J Cardiol"},{"key":"R44-19-20210202","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0002-9149(97)00202-6","article-title":"Value of posterior and right ventricular leads in comparison to the standard 12-lead electrocardiogram in evaluation of ST-segment elevation in suspected acute myocardial infarction.","volume":"79","author":"Zalenski","year":"1997","journal-title":"Am J Cardiol"},{"key":"R45-19-20210202","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0002-9149(98)00861-3","article-title":"Importance of posterior chest leads in patients with suspected myocardial infarction, but nondiagnostic, routine 12-lead electrocardiogram.","volume":"83","author":"Agarwal","year":"1999","journal-title":"Am J Cardiol"},{"key":"R46-19-20210202","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/clinchem\/45.7.1104","article-title":"National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases.","volume":"45","author":"Wu","year":"1999","journal-title":"Clin Chem"},{"key":"R47-19-20210202","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.CIR.97.12.1195","article-title":"Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction.","volume":"97","author":"Theroux","year":"1998","journal-title":"Circulation"},{"key":"R48-19-20210202","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.CIR.88.2.750","article-title":"Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s?","volume":"88","author":"Adams","year":"1993","journal-title":"Circulation"},{"key":"R49-19-20210202","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction.","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R50-19-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2006.02.056","article-title":"Biomarkers in acute cardiac disease: the present and the future.","volume":"48","author":"Jaffe","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R51-19-20210202","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJM199905273402103","article-title":"Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.","volume":"340","author":"Hamm","year":"1999","journal-title":"N Engl J Med"},{"key":"R52-19-20210202","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(99)10285-X","article-title":"Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management.","volume":"354","author":"Heeschen","year":"1999","journal-title":"Lancet"},{"key":"R53-19-20210202","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"key":"R54-19-20210202","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0735-1097(02)02608-6","article-title":"Cardiac troponins in renal insufficiency: review and clinical implications.","volume":"40","author":"Freda","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R55-19-20210202","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00019501-199504000-00009","article-title":"Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes.","volume":"6","author":"Lindahl","year":"1995","journal-title":"Coron Artery Dis"},{"key":"R56-19-20210202","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0002-9149(00)01246-7","article-title":"Diagnostic and prognostic role of myoglobin in patients with suspected acute coronary syndrome. North-Wurttemberg Infarction Study (NOWIS) Group.","volume":"86","author":"Stork","year":"2000","journal-title":"Am J Cardiol"},{"key":"R57-19-20210202","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/hc3801.096336","article-title":"Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I.","volume":"104","author":"McCord","year":"2001","journal-title":"Circulation"},{"key":"R58-19-20210202","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0002-9149(01)01801-X","article-title":"Ninety-minute accelerated critical pathway for chest pain evaluation.","volume":"88","author":"Ng","year":"2001","journal-title":"Am J Cardiol"},{"key":"R59-19-20210202","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.amjcard.2004.06.019","article-title":"A change in serum myoglobin to detect acute myocardial infarction in patients with normal troponin I levels.","volume":"94","author":"Sallach","year":"2004","journal-title":"Am J Cardiol"},{"key":"R60-19-20210202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.CIR.0000134480.06723.D8","article-title":"N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes.","volume":"110","author":"Galvani","year":"2004","journal-title":"Circulation"},{"key":"R61-19-20210202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","article-title":"N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"key":"R63-19-20210202","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7326\/0003-4819-130-9-199905040-00003","article-title":"Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease.","volume":"130","author":"Garber","year":"1999","journal-title":"Ann Intern Med"},{"key":"R64-19-20210202","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2006.07.003","article-title":"ACCF\/ACR\/SCCT\/SCMR\/ASNC\/NASCI\/SCAI\/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology.","volume":"48","author":"Hendel","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R65-19-20210202","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.106.178458","article-title":"Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology.","volume":"114","author":"Budoff","year":"2006","journal-title":"Circulation"},{"key":"R68-19-20210202","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0735-1097(98)00656-1","article-title":"ACC\/AHA expert consensus document: use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology\/American Heart Association.","volume":"33","author":"Cheitlin","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R70-19-20210202","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"R71-19-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-6143.2003.08062.x","article-title":"Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport trials.","volume":"16","author":"Ellis","year":"2003","journal-title":"J Interv Cardiol"},{"key":"R72-19-20210202","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/clc.4960210906","article-title":"Verapamil use in patients with cardiovascular disease: an overview of randomized trials.","volume":"21","author":"Pepine","year":"1998","journal-title":"Clin Cardiol"},{"key":"R73-19-20210202","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/oxfordjournals.eurheartj.a061701","article-title":"Verapamil in acute myocardial infarction.","volume":"5","year":"1984","journal-title":"Eur Heart J"},{"key":"R74-19-20210202","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM198608143150704","article-title":"Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.","volume":"315","author":"Gibson","year":"1986","journal-title":"N Engl J Med"},{"key":"R75-19-20210202","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0002-9149(96)00860-0","article-title":"Sigurd B, et al, for the Danish Verapamil Infarction Trial (DAVIT) Study Group. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone.","volume":"79","author":"Hansen","year":"1997","journal-title":"Am J Cardiol"},{"key":"R78-19-20210202","doi-asserted-by":"crossref","first-page":"18A","DOI":"10.1016\/0002-9149(87)90494-2","article-title":"Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine\/metoprolol Trial (HINT).","volume":"60","author":"Lubsen","year":"1987","journal-title":"Am J Cardiol"},{"key":"R79-19-20210202","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/bmj.312.7039.1143","article-title":"Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?","volume":"312","author":"Beevers","year":"1996","journal-title":"BMJ"},{"key":"R80-19-20210202","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(92)92889-N","article-title":"Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.","volume":"340","author":"Yusuf","year":"1992","journal-title":"Lancet"},{"key":"R81-19-20210202","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.90.4.1731","article-title":"Effects of captopril on ischemic events after myocardial infarction: results of the Survival and Ventricular Enlargement trial. SAVE Investigators.","volume":"90","author":"Rutherford","year":"1994","journal-title":"Circulation"},{"key":"R82-19-20210202","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","article-title":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials.","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"R83-19-20210202","first-page":"145","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published correction appears in N Engl J Med. 2000;342:748].","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"R84-19-20210202","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","article-title":"Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.","volume":"149","author":"Meine","year":"2005","journal-title":"Am Heart J"},{"key":"R85-19-20210202","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"R86-19-20210202","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"key":"R87-19-20210202","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","article-title":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.","volume":"113","author":"Gislason","year":"2006","journal-title":"Circulation"},{"issue":"Suppl 2","key":"R88-19-20210202","first-page":"697","article-title":"Association of treatment with nonsteroidal anti-inflammatory agents (NSAIDs) on study entry with 30 day adverse outcomes among ST elevation MI (STEMI) patients treated with fibrinolytic agent. An EXTRACT-TIMI 25 analysis [abstract].","volume":"114","author":"Gibson","year":"2006","journal-title":"Circulation"},{"key":"R89-19-20210202","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0735-1097(03)00400-5","article-title":"Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry.","volume":"41","author":"Stone","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R90-19-20210202","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study.","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"R91-19-20210202","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease.","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"R92-19-20210202","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"R93-19-20210202","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.","volume":"532","author":"Chan","year":"2005","journal-title":"N Engl J Med"},{"key":"R94-19-20210202","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/bmj.38356.641134.8F","article-title":"Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding.","volume":"330","author":"Leontiadis","year":"2005","journal-title":"BMJ"},{"key":"R95-19-20210202","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"R96-19-20210202","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mhj.2002.126115","article-title":"Borzak S, et al, for the ACUTE II Investigators. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.","volume":"144","author":"Cohen","year":"2002","journal-title":"Am Heart J"},{"key":"R97-19-20210202","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/01.CIR.100.15.1609","article-title":"Intracoronary thrombus and platelet glycoprotein IIb\/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: angiographic results from the PRISM-PLUS trial.","volume":"100","author":"Zhao","year":"1999","journal-title":"Circulation"},{"key":"R98-19-20210202","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.CIR.97.24.2386","article-title":"International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb\/IIIa inhibitor), heparin, or both in unstable angina. Platelet IIb\/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network.","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"R99-19-20210202","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"R100-19-20210202","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"R101-19-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-142-4-200502150-00007","article-title":"A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone.","volume":"142","author":"Schleinitz","year":"2005","journal-title":"Ann Intern Med"},{"key":"R102-19-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a metaanalysis of all major randomised clinical trials.","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"R103-19-20210202","first-page":"1488","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction [published correction appears in N Engl J Med. 1998;339:415].","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"R104-19-20210202","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"R105-19-20210202","first-page":"1429","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study [published correction appears in Lancet. 1997;350:744].","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"R106-19-20210202","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM200106213442502","article-title":"Comparison of two platelet glycoprotein IIb\/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.","volume":"344","author":"Topol","year":"2001","journal-title":"N Engl J Med"},{"key":"R107-19-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0735-1097(94)90539-8","article-title":"Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina.","volume":"24","author":"Holdright","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"R108-19-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"key":"R109-19-20210202","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"key":"R110-19-20210202","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"key":"R111-19-20210202","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes.","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"R112-19-20210202","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes.","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"R113-19-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"R114-19-20210202","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) 11B trial.","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"R115-19-20210202","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.CIR.0000050144.67910.13","article-title":"Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb\/IIIa inhibitor eptifibatide.","volume":"107","author":"Goodman","year":"2003","journal-title":"Circulation"},{"key":"R116-19-20210202","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"R118-19-20210202","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.athoracsur.2004.03.028","article-title":"Does clopidogrel increase blood loss following coronary artery bypass surgery?","volume":"78","author":"Chu","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"R119-19-20210202","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2004.07.014","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction).","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R120-19-20210202","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"R121-19-20210202","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/bmj.316.7141.1337","article-title":"ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.","volume":"316","author":"Baigent","year":"1998","journal-title":"BMJ"},{"key":"R122-19-20210202","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1161\/01.CIR.98.24.2659","article-title":"Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto-1 study. The GISSI Investigators.","volume":"98","author":"Franzosi","year":"1998","journal-title":"Circulation"},{"key":"R123-19-20210202","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-94-6-721","article-title":"Treadmill exercise tests predischarge and six weeks post-myocardial infarction to detect abnormalities of known prognostic value.","volume":"94","author":"Starling","year":"1981","journal-title":"Ann Intern Med"},{"key":"R124-19-20210202","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0735-1097(95)80004-Z","article-title":"Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women.","volume":"26","author":"Marwick","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R125-19-20210202","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199806183382501","article-title":"Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators [published correction appears in N Engl J Med. 1998;339:1091].","volume":"338","author":"Boden","year":"1998","journal-title":"N Engl J Med"},{"key":"R126-19-20210202","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0002-8703(92)90642-9","article-title":"The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease. RISC Study Group.","volume":"123","author":"Nyman","year":"1992","journal-title":"Am Heart J"},{"key":"R127-19-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01797676","article-title":"Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction?","volume":"7","author":"Larsson","year":"1991","journal-title":"Int J Card Imaging"},{"key":"R128-19-20210202","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0140-6736(93)90348-K","article-title":"Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial.","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"R129-19-20210202","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","article-title":"Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration [published correction appears in Lancet. 1994;344:1446].","volume":"344","author":"Yusuf","year":"1994","journal-title":"Lancet"},{"key":"R130-19-20210202","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM198411223112102","article-title":"Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina.","volume":"311","year":"1984","journal-title":"N Engl J Med"},{"key":"R131-19-20210202","first-page":"939","article-title":"Survival data.","volume":"98","year":"1983","journal-title":"Circulation"},{"key":"R132-19-20210202","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/oxfordjournals.eurheartj.a062092","article-title":"Coronary angioplasty of the unstable angina related vessel in patients with multivessel disease.","volume":"7","author":"De Feyter","year":"1986","journal-title":"Eur Heart J"},{"key":"R133-19-20210202","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/0002-9149(88)91154-X","article-title":"Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left ventricular dysfunction: a Coronary Artery Surgery Study Registry Study.","volume":"61","author":"Mock","year":"1988","journal-title":"Am J Cardiol"},{"key":"R134-19-20210202","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.12.001","article-title":"ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R135-19-20210202","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"key":"R136-19-20210202","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"R137-19-20210202","first-page":"e340","article-title":"ACC\/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).","volume":"110","author":"Eagle","year":"2004","journal-title":"Circulation"},{"key":"R138-19-20210202","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/jama.1988.03410150107041","article-title":"Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification.","volume":"260","author":"Yusuf","year":"1988","journal-title":"JAMA"},{"key":"R139-19-20210202","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0022-5223(96)70378-1","article-title":"Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease.","volume":"111","author":"Jones","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R140-19-20210202","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0735-1097(00)00533-7","article-title":"Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status.","volume":"35","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R141-19-20210202","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(95)92896-0","article-title":"First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation).","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"R142-19-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0735-1097(97)00441-5","article-title":"Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease.","volume":"31","author":"Weintraub","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R143-19-20210202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R144-19-20210202","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jacc.2005.11.092","article-title":"Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.","volume":"47","author":"Kotani","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R145-19-20210202","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.","volume":"115","author":"Luscher","year":"2007","journal-title":"Circulation"},{"key":"R146-19-20210202","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R147-19-20210202","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjmed.2006.01.023","article-title":"Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials.","volume":"119","author":"Bavry","year":"2006","journal-title":"Am J Med"},{"key":"R148-19-20210202","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.","volume":"356","author":"Spaulding","year":"2007","journal-title":"N Engl J Med"},{"key":"R149-19-20210202","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","article-title":"Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"R150-19-20210202","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/eurheartj\/ehl282","article-title":"Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.","volume":"27","author":"Nordmann","year":"2006","journal-title":"Eur Heart J"},{"key":"R151-19-20210202","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"key":"R152-19-20210202","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jacc.2004.11.041","article-title":"Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis.","volume":"45","author":"Ferrari","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R153-19-20210202","first-page":"1385","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.","volume":"537","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"R154-19-20210202","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R155-19-20210202","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R156-19-20210202","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jama.285.4.430","article-title":"Early statin treatment following acute myocardial infarction and 1-year survival.","volume":"285","author":"Stenestrand","year":"2001","journal-title":"JAMA"},{"key":"R157-19-20210202","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9149(00)01354-0","article-title":"Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality.","volume":"87","author":"Muhlestein","year":"2001","journal-title":"Am J Cardiol"},{"key":"R158-19-20210202","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1161\/01.CIR.103.23.2768","article-title":"In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now.","volume":"103","author":"Fonarow","year":"2001","journal-title":"Circulation"},{"key":"R159-19-20210202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R160-19-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"R161-19-20210202","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"R162-19-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes.","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"R163-19-20210202","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R164-19-20210202","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2006.04.026","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R165-19-20210202","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jacc.2007.02.020","article-title":"Evidence-based guidelines for cardiovascular disease prevention in women.","volume":"49","author":"Mosca","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R166-19-20210202","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","article-title":"American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"key":"R167-19-20210202","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"R168-19-20210202","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2337\/dc06-9914","article-title":"Nutrition recommendations and interventions for diabetes-2006: a position statement of the American Diabetes Association.","volume":"29","author":"Bantle","year":"2006","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"R169-19-20210202","first-page":"S3","article-title":"2006 Clinical Practice Recommendations.","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"R171-19-20210202","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"},{"key":"R172-19-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"R173-19-20210202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"R175-19-20210202","first-page":"1","article-title":"Cardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute.","volume":"17","author":"Wenger","year":"1995","journal-title":"Clin Pract Guidel Quick Ref Guide Clin"},{"key":"R176-19-20210202","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.91.4.999","article-title":"Depression and 18-month prognosis after myocardial infarction [published correction appears in Circulation. 1998;97:708].","volume":"91","author":"Frasure-Smith","year":"1995","journal-title":"Circulation"},{"key":"R177-19-20210202","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jama.297.8.842","article-title":"Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systemic review and meta-analysis.","volume":"297","author":"Bjelakovic","year":"2007","journal-title":"JAMA"},{"key":"R178-19-20210202","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians.","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"R179-19-20210202","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.308.6933.883","article-title":"Chest pain in women: clinical, investigative, and prognostic features.","volume":"308","author":"Sullivan","year":"1994","journal-title":"BMJ"},{"key":"R180-19-20210202","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease.","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"R181-19-20210202","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction.","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"R182-19-20210202","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group.","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"R183-19-20210202","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-201001000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:39:59Z","timestamp":1618036799000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201001000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":174,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181727d06","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}